A Harvard Stem Cell Institute (HSCI) led collaboration developed a bioartificial pancreas, which offers the potential for faster, more effective treatment of Type 1 diabetes.
- What they did: Developed a new kind of macroencapsulation device to protect the insulin-producing cells in the pancreas.
- What they found: This new device offers protection from the immune system while allowing cell nutrients to pass through.
- Why it matters: This convection-enhanced macroencapsulation device offers the possibility of better treatment for the more than 40 million worldwide who suffer from Type 1 diabetes.
|
|